orywireNews that matters in AmericaReporting on public life, technology, money, and policy in the United States.
orywireNHS reporting and analysis from Zorywire.
NHS England says eligible men with early, low or intermediate-risk prostate cancer will be offered SABR radiotherapy, a more targeted treatment usually given in five doses. Patients should ask their specialist team whether it is suitable for their diagnosis and treatment plan.
